Method and composition for detection of human chronic myelogenous leukemia
US4599305A · kind A · utility
19Cited by
4References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 16, 1984 |
| Grant date | Jul 8, 1986 |
| Priority date | — |
| Expiry date | Jul 16, 2004 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/806
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
A method for detecting chronic myelogenous leukemia in a human comprising the step of testing a biological sample from a patient to determine the presence of a marker protein (P210) which is characterized as a c-abl protein having tyrosine kinase activity and a molecular weight of approximately 210,000. Antisera which are specific for the P210 protein are disclosed which can be used to precipitate the P210 protein to allow identification by gel electrophoresis or other technique.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.